Confronting the opioid crisis with basic research in neuropharmacology Editorial

   

Authors:	Baumann, M. H.; Pasternak, G. W.; Negus, S. S.
Title:	Confronting the opioid crisis with basic research in neuropharmacology
Keywords:	unclassified drug; drug safety; nonhuman; united states; drug targeting; pain; midazolam; opiate; editorial; health care policy; prescription; drug fatality; interdisciplinary communication; sex difference; methadone; morphine; respiration depression; g protein coupled receptor; mu opiate receptor; mu opiate receptor agonist; basic research; medical expert; international cooperation; fentanyl; diamorphine; opiate addiction; drug overdose; reward; buprenorphine; chemokine receptor ccr5; neurobiology; law enforcement; dopamine receptor stimulating agent; brain hypoxia; reinforcement; drug self administration; human; priority journal; delta opiate receptor antagonist; kappa opiate receptor agonist; carfentanil; drug dependence treatment; neuropharmacology; dopamine 3 receptor blocking agent; mp 1104; oliceridine; rvk 440; intracranial self-stimulation test
Journal Title:	Neuropharmacology
Volume:	166
ISSN:	0028-3908
Publisher:	Pergamon-Elsevier Science Ltd
Date Published:	2020-04-01
Start Page:	107972
Language:	English
DOI:	10.1016/j.neuropharm.2020.107972
PUBMED:	31958407
PROVIDER:	scopus
PMCID:	PMC8281381
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078255614&doi=10.1016%2fj.neuropharm.2020.107972&partnerID=40&md5=e2a02e37feaa612e37411bac79af4317
Notes:	Editorial -- Export Date: 2 March 2020 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/162113